{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:18:25Z","timestamp":1790349505024,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jsps.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T02:51:55Z","timestamp":1525402315000},"page":"943-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The relationship between blood eosinophil count and disease activity in ankylosing spondylitis patients treated with TNF-\u03b1 inhibitors"],"prefix":"10.1007","volume":"26","author":[{"given":"Gokhan","family":"Sargin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taskin","family":"Senturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Yavasoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"10","key":"10.1016\/j.jsps.2018.05.001_b0005","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1002\/eji.1830271018","article-title":"A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55\/p75 TNF receptor signaling","volume":"27","author":"Alexopoulou","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.jsps.2018.05.001_b0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/S0482-50042012000100011","article-title":"Leukopenia and thrombocytopenia induced by etanercept: two case reports and literature review","volume":"52","author":"Azevedo","year":"2012","journal-title":"Rev. Bras. Reumatol."},{"issue":"6","key":"10.1016\/j.jsps.2018.05.001_b0015","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00296-012-2539-5","article-title":"Monoclonal anti-TNF antibodies can elevate hemoglobin level in patients with ankylosing spondylitis","volume":"33","author":"Bes","year":"2013","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.jsps.2018.05.001_b0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/09546634.2015.1079299","article-title":"Eosinophilia\u2013a rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis","volume":"27","author":"Chiriac","year":"2016","journal-title":"J. Dermatolog. Treat."},{"issue":"1","key":"10.1016\/j.jsps.2018.05.001_b0025","first-page":"200","article-title":"Severe neutrophilia induced by infliximab for psoriasis","volume":"158","author":"de Oliveira","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jsps.2018.05.001_b0030","unstructured":"eHealthMe. Available from: http:\/\/ www.ehealthme.com."},{"issue":"5","key":"10.1016\/j.jsps.2018.05.001_b0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.46.5.403","article-title":"Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment","volume":"46","author":"Feltelius","year":"1987","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jsps.2018.05.001_b0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/1521-4141(200202)32:2<457::AID-IMMU457>3.0.CO;2-1","article-title":"Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis","volume":"32","author":"Fujihara","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.jsps.2018.05.001_b0045","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.jsps.2018.05.001_b0050","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1177\/0300060517708693","article-title":"Association of adipokines, interleukin-6, and tumor necrosis factor-\u03b1 concentrations with clinical characteristics and presence of spinal syndesmophytes in patients with ankylosing spondylitis: a cross-sectional study","volume":"45","author":"Gonzalez-Lopez","year":"2017","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"10.1016\/j.jsps.2018.05.001_b0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0378-6323.129422","article-title":"Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis","volume":"80","author":"Guidelli","year":"2014","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.jsps.2018.05.001_b0060","first-page":"111","article-title":"TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis","volume":"1","author":"Jacobsen","year":"1994","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.jsps.2018.05.001_b0065","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1034\/j.1600-0609.2003.00115.x","article-title":"Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor","volume":"71","author":"Kuruvilla","year":"2003","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"10.1016\/j.jsps.2018.05.001_b0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12016-015-8507-6","article-title":"The eosinophil in health and disease: from bench to bedside and back","volume":"50","author":"Liao","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.jsps.2018.05.001_b0075","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.4238\/2015.June.18.28","article-title":"Expression of TNF-\u03b1, VEGF, and MMP-3 mRNAs in synovial tissues and their roles in fibroblast-mediated osteogenesis in ankylosing spondylitis","volume":"14","author":"Liu","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.jsps.2018.05.001_b0080","doi-asserted-by":"crossref","unstructured":"Liu, R., Yue, Z., Peng, X., Wang, X., Feng, Z., Wan, L. 2016. Association Between Intercellular Adhesion Molecule-1, -2, -3 Plasma Levels and Disease Activity of Ankylosing Spondylitis in the Chinese Han Population. Spine (Phila Pa 1976). 41:618\u2013624.","DOI":"10.1097\/BRS.0000000000001328"},{"issue":"4","key":"10.1016\/j.jsps.2018.05.001_b0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000334805","article-title":"Eosinophilia during psoriasis treatment with TNF antagonists","volume":"223","author":"Malisiewicz","year":"2011","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jsps.2018.05.001_b0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1756-185X.2012.01740.x","article-title":"Severe pancytopenia following etanercept administration in rheumatoid arthritis","volume":"15","author":"Mart\u00ednez Santana","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jsps.2018.05.001_b0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0014-5793(97)00857-0","article-title":"Activation of transcription factor NF-kappa B by phagocytic stimuli in human neutrophils","volume":"412","author":"McDonald","year":"1997","journal-title":"FEBS Lett."},{"issue":"7568","key":"10.1016\/j.jsps.2018.05.001_b0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/bmj.38954.689583.DE","article-title":"Diagnosis and management of ankylosing spondylitis","volume":"333","author":"McVeigh","year":"2006","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.jsps.2018.05.001_b0105","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s10067-006-0415-y","article-title":"Antitumor necrosis factor-induced neutropenia: a case report with double positive rechallenges","volume":"26","author":"Montan\u00e9","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jsps.2018.05.001_b0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.18433\/J3WP4F","article-title":"Safety of anti-tumor necrosis factor therapies in arthritis patients","volume":"17","author":"Nanau","year":"2014","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jsps.2018.05.001_b0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/1354750X.2016.1278265","article-title":"Plasma levels of pentraxin 3 in patients with spondyloarthritis","volume":"23","author":"Nisihara","year":"2018","journal-title":"Biomarkers"},{"issue":"9","key":"10.1016\/j.jsps.2018.05.001_b0120","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrd1175","article-title":"Anti-TNF-alpha therapies: the next generation","volume":"2","author":"Palladino","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jsps.2018.05.001_b0125","doi-asserted-by":"crossref","unstructured":"Seng, J.J.B., Kwan, Y.H., Low, L.L., Thumboo, J., Fong, W.S.W. 2018. Role of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and mean platelet volume (MPV) in assessing disease control in Asian patients with axial spondyloarthritis. Biomarkers.","DOI":"10.1080\/1354750X.2018.1425916"},{"issue":"25","key":"10.1016\/j.jsps.2018.05.001_b0130","doi-asserted-by":"crossref","first-page":"18542","DOI":"10.1016\/S0021-9258(17)46661-0","article-title":"Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor","volume":"268","author":"Tartaglia","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jsps.2018.05.001_b0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/cyto.2001.0890","article-title":"Mechanism of tumour necrosis factor alpha mediated eosinophil survival","volume":"15","author":"Temkin","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.jsps.2018.05.001_b0140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000053596","article-title":"Tumor necrosis factor-alpha mediates antiapoptotic signals partially via p38 MAP kinase activation in human eosinophils","volume":"120","author":"Tsukahara","year":"1999","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.jsps.2018.05.001_b0145","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.jsps.2018.05.001_b0150","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1468-3083.2011.04169.x","article-title":"Transient blood eosinophilia during treatment with Adalimumab","volume":"26","author":"Vester","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"7","key":"10.1016\/j.jsps.2018.05.001_b0155","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1074\/jbc.274.7.4309","article-title":"NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro","volume":"274","author":"Ward","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jsps.2018.05.001_b0160","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/rheumatology\/kem332","article-title":"Three significant cases of neutropenia with etanercept","volume":"47","author":"Wenham","year":"2008","journal-title":"Rheumatology (Oxford)"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418301026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418301026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:32:10Z","timestamp":1736184730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016418301026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1319016418301026"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2018.05.001","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between blood eosinophil count and disease activity in ankylosing spondylitis patients treated with TNF-\u03b1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}